Extra oxygen may boost exercise in lung disease patients

NCT ID NCT02551068

Completed Symptom relief Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether breathing 60% oxygen during exercise helps people with idiopathic pulmonary fibrosis (IPF) who are taking nintedanib. 78 participants exercised on a bike or walked while getting either high oxygen or standard care. The goal was to see if they could exercise longer and feel less breathless after 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 60% oxygen
What this could lead to: If it works, this could point toward a simple way to help IPF patients exercise longer and feel less breathless.
What could go wrong: This is a small, completed study with 78 participants. The results may not apply to all IPF patients, and the benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IDIOPATHIC PULMONARY FIBROSIS

Contacts and locations

Locations

Laval University

Québec, Quebec, G1V 0A6, Canada
McGill University

Montreal, Quebec, H3A 0G4, Canada
McMaster University

Hamilton, Ontario, L8S 4L8, Canada
Queens University

Kingston, Ontario, K7L 3N6, Canada
St. Paul's Hospital

Vancouver, British Columbia, V6Z1Y6, Canada
UBC Okanagan

Kelowna, British Columbia, V1V 1V7, Canada
University of Alberta

Edmonton, Alberta, T6G 2R3, Canada
University of Calgary

Calgary, Alberta, T3M1M4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.